Last reviewed · How we verify

co.don AG — Portfolio Competitive Intelligence Brief

co.don AG pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
co.don chondrosphere® co.don chondrosphere® phase 3 Cell-based therapy Orthopedics

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. State-Financed Health Facility "Samara Regional Medical Center Dinasty" · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for co.don AG:

Cite this brief

Drug Landscape (2026). co.don AG — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/co-don-ag. Accessed 2026-06-10.

Related